The management of otosclerosis is viewed by many as the sine qua non of an otologic practice. From the elegant otopathologic descriptions by Ádám Politzer1 in the 19th century to surgical breakthroughs by Julius Lempert2 and John Shea Jr3 in the mid-20th century, otosclerosis and its surgical management have inspired generations of students, researchers, and surgeons alike. The allure of stapedectomy may be, in part, the elegant tightrope walk to fix hearing loss along with the anticipation of a surgeon report card that arrives in the form of an audiogram. Although the surgical treatment of otosclerosis has not drastically changed since its description by Shea,3 otosclerosis and its management remain fertile ground for research, debate, and refinement. Indeed, novel 21st-century diagnoses—such as superior canal dehiscence syndrome; technological refinements, including otoendoscopy; and even inner-ear drug delivery4—appear to be viewed in connection to otosclerosis.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Kozin ED. What If a Stapedectomy Were Not Cost-effective? JAMA Otolaryngol Head Neck Surg. Published online November 07, 2019. doi:https://doi.org/10.1001/jamaoto.2019.3366
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: